Product Information

PREMARIN 0.45 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $6.9521 per EA under NDC 00046110181. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREMARIN 0.45 MG TABLET

estrogens, conjugated
$6.9521per EA

Strength

.45 mg/1

NDC

00046110181

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ESTROGENS, CONJUGATED

Approval Type

New Drug (NDA)

FDA Application

NDA004782

FDA Approved

Before 1982

TE Code

AB

On Market Since

1/1/2006

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Estrogens
Conjugated (USP)

Price Statistics

The NADAC for PREMARIN 0.45 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 148.8%. The table below summarizes its recorded NADAC range and movement.

Current price$6.9521 per EA
All-time high$6.9689 (Jun 10, 2026)
All-time low$2.7943 (Nov 28, 2013)
52-week high$6.9689
52-week low$6.7559
Median price$5.6541
Average price$5.4397
Largest weekly change+9.4% (Jun 11, 2014)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

+0.2%

1Y

+2.9%

3Y

+8.2%

5Y

+17.1%

All

+148.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 23%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREMARIN 0.45 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PREMARIN 0.45 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $6.9521 per EA (NDC 00046110181), effective Nov 11, 2026.

How has the price of PREMARIN 0.45 MG TABLET changed over time?

Over the history we have for it, the NADAC for PREMARIN 0.45 MG TABLET has risen 148.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PREMARIN 0.45 MG TABLET?

Since Nov 28, 2013, the NADAC for PREMARIN 0.45 MG TABLET has ranged from a low of $2.7943 (Nov 28, 2013) to a high of $6.9689 (Jun 10, 2026), with a median of $5.6541 per EA.

Are there cheaper alternatives to PREMARIN 0.45 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CONJUGATED ESTROGENS 0.45 MG TB, is $5.3479 per EA — about 23% below PREMARIN 0.45 MG TABLET.

Who manufactures PREMARIN 0.45 MG TABLET?

PREMARIN 0.45 MG TABLET (NDC 00046110181) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.